|
English
|
正體中文
|
简体中文
|
2817371
|
|
???header.visitor??? :
27759802
???header.onlineuser??? :
213
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"park s r"???jsp.browse.items-by-author.description???
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-01-28T01:06:35Z |
Management of gastric cancer in Asia: Resource-stratified guidelines
|
Shen L.;Shan Y.-S.;Hu H.-M.;Price T.J.;Sirohi B.;Kun-Huei Yeh;Yang Y.-H.;Sano T.;Yang H.-K.;Zhang X.;Park S.R.;Fujii M.;Kang Y.-K.;Chen L.-T.; Shen L.; Shan Y.-S.; Hu H.-M.; Price T.J.; Sirohi B.; KUN-HUEI YEH; Yang Y.-H.; Sano T.; Yang H.-K.; Zhang X.; Park S.R.; Fujii M.; Kang Y.-K.; Chen L.-T. |
| 國立成功大學 |
2013-06 |
A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma
|
Roy, A. C.; Park, S. R.; Cunningham, D.; Kang, Y. K.; Chao, Y.; Chen, L. T.; Rees, C.; Lim, H. Y.; Tabernero, J.; Ramos, F. J.; Kujundzic, M.; Cardic, M. B.; Yeh, C. G.; de Gramont, A. |
Showing items 1-2 of 2 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
